DTC vs MBRX
DTC (DTC) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
DTC (DTC) common stock.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
DTC does not have a complete income-statement cache yet.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
MBRX currently screens at market cap $8.2M.
Not investment advice. Open the DTC and MBRX stock pages for the full models.
Not investment advice.